- Inhibitors
- Antibodies
- Compound Libraries
- New Products
- Contact Us
-
Australia
-
Austria
-
Belgium
-
Brazil
-
Canada
-
China
-
Czech Republic
-
Denmark
-
Finland
-
France
-
Germany
-
Greece
-
Hong Kong
-
Hungary
-
Iceland
-
India
-
Ireland
-
Israel
-
Italy
-
Japan
-
Korea
-
Luxembourg
-
Malaysia
-
Netherlands
-
New Zealand
-
Norway
-
Poland
-
Qatar
-
Romania
-
Saudi Arabia
-
Singapore
-
Spain
-
Sweden
-
Switzerland
-
Taiwan
-
Turkey
-
United Kingdom
-
United States
For research use only. Not for use in humans.
Istiratumab (Anti-HER3 & IGF-1R)
Synonyms: MM-141
Istiratumab is a fully human tetravalent bispecific antibody that binds to and co-inhibits IGF-1R and the epidermal growth factor family of receptor tyrosine kinases B3 (ErbB3), with potential anti-tumor activity. MW: 199.64 KD.
| Featured Inhibitors | Y-27632 Dihydrochloride SB431542 CHIR-99021 (Laduviglusib) RMC-7977 RMC-6236 (Daraxonrasib) MRTX1133 MG132 Z-VAD-FMK VT3989 IAG933 |
|---|
Specificity
| Name | Citation | HER2 | Others |
|---|---|---|---|
| Canertinib (CI-1033) | 48 | EGFR | |
| CP-724714 | 109 | ||
| Sapitinib (AZD8931) | 50 | ErbB3,EGFR | |
| CUDC-101 | 23 | EGFR,HDAC,HDAC1 | |
| Mubritinib (TAK 165) | 40 | ||
| AEE788 (NVP-AEE788) | 13 | EGFR,c-Abl,FLT1 | |
| AC480 (BMS-599626) | 10 | HER1,HER4 | |
| TAK-285 | 4 | EGFR/HER1,HER4,MEK1 | |
| Tyrphostin AG 879 | 3 | Trk | |
| Tuxobertinib (BDTX-189) | 2 | EGFR,RIPK2,BLK | |
| Epertinib hydrochloride | 0 | EGFR,HER4 | |
| TAS0728 | 1 | ||
| Tyrphostin AG-528 | 0 | EGFR | |
| SU5204 | 1 | VEGFR-2 | |
| Pyrotinib dimaleate | 4 | EGFR | |
| Poziotinib (HM781-36B) | 35 | HER1,HER4 | |
| HER2-Inhibitor-1 | 1 | ||
| Zongertinib | 1 | EGFR-Ex20ins | |
| Nordihydroguaiaretic acid (NDGA) | 1 | p300,IGF-1R,lipoxygenase | |
| EGCG ((-)-Epigallocatechin Gallate) | 42 | FASN,EGFR,DNMT |
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.
Mechanism of Action
| Description |
Istiratumab is a fully human tetravalent bispecific antibody that binds to and co-inhibits IGF-1R and the epidermal growth factor family of receptor tyrosine kinases B3 (ErbB3), with potential anti-tumor activity. MW: 199.64 KD.
|
|---|
Product Details
| CAS No. | 1509928-04-4 |
|---|---|
| Source | CHO |
| Storage (From the date of receipt) |
-80℃(avoid freeze-thaw cycles) |
Comparison of Clones for
*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)
Tech Support
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.
Products are for research use only. Not for human use. We do not sell to patients.
©Copyright 2013 Selleck Chemicals. All Rights Reserved.